{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:09:13Z","timestamp":1763665753116,"version":"3.41.2"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Intraoperative use of an antibacterial envelope during surgery for cardiac implantable electronic device (CIED) surgery reduces infection risk at increased procedural costs. The objective of this systematic review was to synthesize the published economic literature on the cost-effectiveness of the antibacterial envelope.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A systematic review of the published literature was conducted to identify economic evaluations (i.e. cost-utility, cost-effectiveness, and cost-benefit studies) comparing the antibacterial envelope compared with standard of care in preventing post-operative CIED infection. Systematic review best practices were followed, and study quality was assessed. Of 142 unique citations, 7 studies met the inclusion criteria for qualitative synthesis. All cost-effectiveness studies were conducted from the healthcare payer perspective of high-income countries. The base case analysis of most economic studies (5\/7) reported a cost per quality-adjusted life year gained that exceeded country-specific societal thresholds for good value in healthcare. Cost-effectiveness was highly dependent on the baseline infection risk. That is, at current pricing, the antibacterial envelope may be cost-effective at base infection rates of greater than 3%, and cost-savings at infection rates that exceed 6%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Routine use of an antibacterial envelope in patients undergoing CIED procedures (implantation or revision) is unlikely to be cost-effective except among those at high risk for post-operative infection. Individualized risk assessment may help guide efficient and value-based use of this technology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euaf121","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:02:22Z","timestamp":1750050142000},"source":"Crossref","is-referenced-by-count":2,"title":["Cost-effectiveness of an intraoperative antibacterial envelope in preventing cardiac implantable device-associated infections: a systematic review"],"prefix":"10.1093","volume":"27","author":[{"given":"Sathvika","family":"Mudigonda","sequence":"first","affiliation":[{"name":"Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5637-8967","authenticated-orcid":false,"given":"Ethan","family":"Hagarty","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-7697","authenticated-orcid":false,"given":"Lucy","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia , Vancouver, Bc ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9884-6423","authenticated-orcid":false,"given":"Elissa","family":"Rennert-May","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"Department of Medicine, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"O\u2019Brien Institute for Public Health, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"Department of Microbiology, Immunology and Infectious Diseases, University of Calgary , Calgary, AB ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-688X","authenticated-orcid":false,"given":"Jacqueline","family":"Joza","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek V","family":"Exner","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason","family":"Andrade","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia , Vancouver, Bc ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-3785","authenticated-orcid":false,"given":"Satish R","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-7485","authenticated-orcid":false,"given":"Derek S","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"Department of Community Health Sciences, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"Department of Medicine, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]},{"name":"O\u2019Brien Institute for Public Health, University of Calgary , 3280 Hospital Dr NW, Calgary, AB , T2N 4Z6","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2025071802314771800_euaf121-B1","doi-asserted-by":"crossref","first-page":"euad208","DOI":"10.1093\/europace\/euad208","article-title":"Cardiac implantable electronic device implantation and device-related infection","volume":"25","author":"Modi","year":"2023","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B2","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch Intern Med"},{"key":"2025071802314771800_euaf121-B3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/euu147","article-title":"Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival","volume":"16","author":"Tarakji","year":"2014","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B4","doi-asserted-by":"crossref","first-page":"euae169","DOI":"10.1093\/europace\/euae169","article-title":"Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?","volume":"26","author":"Wright","year":"2024","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B5","doi-asserted-by":"crossref","first-page":"euad274","DOI":"10.1093\/europace\/euad274","article-title":"Real-world evidence on the association between cardiac implantable electronic device infection and all-cause mortality","volume":"25","author":"Shawon","year":"2023","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/pace.13300","article-title":"Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection","volume":"41","author":"Greenspon","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025071802314771800_euaf121-B7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/ice.2023.48","article-title":"Complex cardiac implantable electronic device infections in Alberta, Canada: an epidemiologic cohort study of validated administrative data","volume":"44","author":"King","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025071802314771800_euaf121-B8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/pace.12518","article-title":"Increased long-term mortality in patients with cardiovascular implantable electronic device infections","volume":"38","author":"Rizwan Sohail","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025071802314771800_euaf121-B9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.31083\/j.rcm2406176","article-title":"Prevention of cardiac implantable electronic device infections: a review","volume":"24","author":"S\u0142awi\u0144ski","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"2025071802314771800_euaf121-B10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/cer-2017-0080","article-title":"Incidence and costs of cardiac device infections: retrospective analysis using German health claims data","volume":"7","author":"Ludwig","year":"2018","journal-title":"J Comp Eff Res"},{"key":"2025071802314771800_euaf121-B11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/13696998.2017.1409227","article-title":"Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection","volume":"21","author":"Kay","year":"2018","journal-title":"J Med Econ"},{"key":"2025071802314771800_euaf121-B12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13756-023-01347-4","article-title":"The economic burden of cardiac implantable electronic device infections in Alberta, Canada: a population-based study using validated administrative data","volume":"12","author":"Rennert-May","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025071802314771800_euaf121-B13","first-page":"1783","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"381","author":"Tarakji","year":"2019","journal-title":"N Engl J Med"},{"key":"2025071802314771800_euaf121-B14","doi-asserted-by":"crossref","first-page":"36206","DOI":"10.31083\/RCM36206","article-title":"Economic evaluations in electrophysiology in the last 15 years: a systematic review of the literature","volume":"26","author":"Mei","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"2025071802314771800_euaf121-B15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14737167.2016.1246960","article-title":"How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1\/3)","volume":"16","author":"van Mastrigt","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2025071802314771800_euaf121-B16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","article-title":"How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3)","volume":"16","author":"Wijnen","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2025071802314771800_euaf121-B17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025071802314771800_euaf121-B18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"2025071802314771800_euaf121-B19","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1016\/j.ejcskn.2023.100008","article-title":"A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma","volume":"1","author":"van Delft","year":"2023","journal-title":"EJC Skin Cancer"},{"key":"2025071802314771800_euaf121-B20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13023-021-01695-7","article-title":"Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments","volume":"16","author":"Dangouloff","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2025071802314771800_euaf121-B21","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.120.029340","article-title":"Cost-effectiveness of extended electrocardiogram monitoring for atrial fibrillation after stroke: a systematic review","volume":"51","author":"Chew","year":"2020","journal-title":"Stroke"},{"author":"Government of Canada","key":"2025071802314771800_euaf121-B22"},{"key":"2025071802314771800_euaf121-B23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jval.2020.12.021","article-title":"Cost-effectiveness analyses of an absorbable antibacterial envelope for use in patients at increased risk of cardiac implantable electronic device infection in Germany, Italy, and England","volume":"24","author":"Boriani","year":"2021","journal-title":"Value Health"},{"key":"2025071802314771800_euaf121-B24","doi-asserted-by":"crossref","first-page":"euad159","DOI":"10.1093\/europace\/euad159","article-title":"Cost-effectiveness of an antibacterial envelope for infection prevention in patients undergoing cardiac resynchronization therapy reoperations in Denmark","volume":"25","author":"Frausing","year":"2023","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B25","doi-asserted-by":"crossref","first-page":"e012446","DOI":"10.1161\/CIRCEP.123.012446","article-title":"The BLISTER score: a novel, externally validated tool for predicting cardiac implantable electronic device infections, and its cost-utility implications for antimicrobial envelope use","volume":"17","author":"Maclean","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025071802314771800_euaf121-B26","doi-asserted-by":"crossref","first-page":"e008443","DOI":"10.1161\/CIRCOUTCOMES.121.008443","article-title":"Cost-effectiveness of antibiotic-eluting envelope for prevention of cardiac implantable electronic device infections in heart failure","volume":"15","author":"Modi","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025071802314771800_euaf121-B27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euaa291","article-title":"Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection","volume":"23","author":"Rennert-May","year":"2021","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B28","doi-asserted-by":"crossref","first-page":"e008503","DOI":"10.1161\/CIRCEP.120.008503","article-title":"Cost-effectiveness of an antibacterial envelope for cardiac implantable electronic device infection prevention in the US healthcare system from the WRAP-IT trial","volume":"13","author":"Wilkoff","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2025071802314771800_euaf121-B29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jval.2016.02.020","article-title":"On the estimation of the cost-effectiveness threshold: why, what, how?","volume":"19","author":"Vallejo-Torres","year":"2016","journal-title":"Value Health"},{"key":"2025071802314771800_euaf121-B30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jacc.2019.09.060","article-title":"Risk factors for infections involving cardiac implanted electronic devices","volume":"74","author":"Birnie","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025071802314771800_euaf121-B31","doi-asserted-by":"crossref","first-page":"e230178","DOI":"10.57264\/cer-2023-0178","article-title":"The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health","volume":"13","author":"Balijepalli","year":"2024","journal-title":"J Comp Eff Res"},{"key":"2025071802314771800_euaf121-B32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"2025071802314771800_euaf121-B33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/europace\/euz246","article-title":"European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"22","author":"Blomstr\u00f6m-Lundqvist","year":"2020","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/europace\/euab232","article-title":"2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"24","author":"Glikson","year":"2022","journal-title":"Europace"},{"author":"National Institute for Health and Care Excellence","key":"2025071802314771800_euaf121-B35"},{"key":"2025071802314771800_euaf121-B36","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/europace\/euab028","article-title":"Use of healthcare claims to validate the prevention of arrhythmia device infection trial cardiac implantable electronic device infection risk score","volume":"23","author":"Ahmed","year":"2021","journal-title":"Europace"},{"key":"2025071802314771800_euaf121-B37","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.jacc.2018.09.068","article-title":"Prevention of arrhythmia device infection trial: the PADIT trial","volume":"72","author":"Krahn","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025071802314771800_euaf121-B38","doi-asserted-by":"crossref","first-page":"e011740","DOI":"10.1161\/CIRCEP.122.011740","article-title":"Randomized trial of stand-alone use of the antimicrobial envelope in high-risk cardiac device patients","volume":"16","author":"Ellis","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euaf121\/63496875\/euaf121.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/7\/euaf121\/63496875\/euaf121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/27\/7\/euaf121\/63496875\/euaf121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T06:31:55Z","timestamp":1752820315000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf121\/8163512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf121","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"type":"print","value":"1099-5129"},{"type":"electronic","value":"1532-2092"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,16]]},"article-number":"euaf121"}}